Please use this discussion page to post any comments or questions you may have regarding topics discussed during Session 14 on Polypharmacy. Recall that the purpose of this board is to share resources, ask questions and support each other within the ECHO community. Before posting your questions/comments, please review the rules:
– Please practice non-judgement and respect for others. Only share evidence-based best practices in patient care.
– Please do not share any identifiable patient information on the message board
– Promotion of any for-profit entity such as a pharmaceutical organization or medical device company is strictly prohibited.
– All recommendations made are strictly for education purposes or advice, and are not strict medical orders. The primary care provider takes sole responsibility in the care of the patient.